Edward N. Libby, MD

Edward Libby is a board certified Hematologist and Associate Professor of Oncology, Hematology and Medicine at the Seattle Cancer Care Alliance and the University of Washington. His practice and research focus are in clinical trials for patients with multiple myeloma, Waldenström macroglobulinemia and amyloidosis.

He received his BS from the University of Texas at El Paso and his MD from the University of Texas Health Science Center at Houston. He completed internal medicine residency at the University of New Mexico (UNM) in Albuquerque.

Representative Publications:
Pre-Transplantation Novel Agent Induction Predicts Progression-Free Survival for Patients With Immunoglobulin Light-Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation
Panobinostat: A Review of Trial Results and Future Prospects in Multiple Myeloma
Utilization of Stored Autologous Pbscs to Support Second Autologous Transplantation in Multiple Myeloma Patients in the Era of Novel Agent Therapy
Disease-Specific Survival for Patients With Multiple Myeloma: Significant Improvements Over Time in all Age Groups